Scinai Immunotherapeutics ( ($SCNI) ) has issued an announcement. On December 22, 2025, Scinai Immunotherapeutics Ltd. held its Annual Meeting of ...

Scinai Immunotherapeutics Ltd., a biopharmaceutical company, focuses on developing, manufacturing, and commercializing inflammation and immunology biological products for the treatment of infectious ...

Scinai Immunotherapeutics Ltd. ADR Annual stock financials by MarketWatch. View the latest SCNI financial statements, income statements and financial ratios.

Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on their ...

Scinai Immunotherapeutics (NASDAQ: SCNI) is a biopharmaceutical company focused on developing inflammation and immunology (“I&I”) biological products and providing CDMO services through its Scinai ...

About 125 million people worldwide have psoriasis, a chronic disease where the immune system becomes overactive, causing skin cells to multiply too quickly The psoriasis treatment market is expected ...

Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these ...

SCNI is trading near the bottom of its 52-week range and below its 200-day simple moving average. Price change The price of SCNI shares has decreased $0.04 since the market last closed. This is a 4.78 ...